Assisted Reproductive Technology Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2021-2026

Report Code: HCR 18278 Report Format: PDF + Excel (Delivery in 48 Hrs)

Assisted Reproductive Technology Market Overview

Assisted Reproductive Technology Market size is estimated to reach $46.2 billion by 2026, growing at a CAGR of 9.6% during the forecast period 2021-2026. Assisted reproductive technology covers medical procedures that are helpful to address infertility. It covers various methods, such as cryopreservation, in-vitro fertilization, and many others. These procedures depending on situation also use donor eggs, sperm, and previously frozen embryos and also involve a surrogate and gestational carrier. This procedure involves the manipulation of sperm and embryos for producing a pregnancy. The rise in the adoption of ovulation induction, artificial insemination, and hysterosalpingography in developed nations, increase in the median age of first-time motherhood, and growing favorable policies for infertility treatment are the factors that are set to drive the growth of the Assisted Reproductive Technology Market for the period 2021-2026.

Report Coverage                                                                                     

The report: “Assisted Reproductive Technology Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Assisted Reproductive Technology Market.        
By Type: Ovulation Induction, Artificial Insemination, Surrogacy, and Others.
By Procedure: Fresh Nondonor, Frozen Nondonor, Fresh Donor, and Frozen Donor.
By End User: Hospitals, Fertility Clinics, Clinical Research Institutes, and Others.   
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World (Middle East and Africa).

Key Takeaways

  • Geographically, North America Assisted Reproductive Technology Market accounted for the highest revenue share in 2020 and it is poised to dominate over the period 2021-2026 owing to the growing adoption of ovulation induction and artificial insemination infertility clinics.
  • The rise in the demand for cryopreservation and hysterosalpingography procedures is driving the Fertility Clinics segment. However, the high cost of assisted reproductive technology procedures is one of the major factors that is said to reduce the growth of the Assisted Reproductive Technology Market.
  • Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Assisted Reproductive Technology Market report.

Assisted Reproductive Technology Market: Market Share (%) By End User, 2020

Assisted Reproductive Technology Market

For more details on this report - Request for Sample

Assisted Reproductive Technology Market Segment Analysis-By Procedure

The Assisted Reproductive Technology Market based on the Procedure can be further segmented into Fresh Nondonor, Frozen Nondonor, Fresh Donor, and Frozen Donor. The Fresh Nondonor segment held the largest share in 2020 and is also estimated to be the fastest growing segment with a CAGR of 10.4% over the period 2021-2026. This growth is owing to the factors such as rise in the success rate of the procedure in the first attempt and increase in the demand for assisted reproductive technologies, such as cryopreservation and artificial insemination. 

The growing number of fresh nondonors banking the eggs or embryos is driving the growth of the Assisted Reproductive Technology Market. The Frozen Non-donor segment held the second largest share in 2020 owing to its cost-effectiveness and also the drug stimulation process is not required for the recipient and is less invasive. Many favorable policies in developed nations also encouraged people to donate their sperm, which is driving the growth of the Assisted Reproductive Technology Market.

Assisted Reproductive Technology Market Segment Analysis-By End User

The Assisted Reproductive Technology Market based on the End User can be further segmented into Hospitals, Fertility Clinics, Clinical Research Institutes, and Others. The Fertility Clinics segment held the largest share in 2020 and is also estimated to be the fastest growing segment with a CAGR of 10.6% over the period 2021-2026. This growth is owing to the factors such as growing demand for ART treatments and rise in the number of fertility clinics in developed nations. 

The rise in the adoption of cryopreservation and hysterosalpingography is driving the growth of the Assisted Reproductive Technology Market. The Hospitals segment held the second largest share in 2020 owing to the factors such as low treatment costs and growing adoption of hospital-based environment for the treatment of In-vitro fertilization (IVF) and intrauterine insemination (IUI).

Assisted Reproductive Technology Market Segment Analysis-By Geography

North America held the largest share with 31% of the overall market in 2020. The growth in this segment is owing to the factors such as rise in the number of fertility centers and growing favorable policies for infertility treatment. The rise in the adoption of ovulation induction and artificial insemination infertility clinics is driving the growth of the Assisted Reproductive Technology Market. Asia-Pacific segment is estimated to be the fastest growing segment over the period 2021-2026. The growth in this segment is owing to the factors such as growing demand for the adoption of cryopreservation and hysterosalpingography and rise in the government support for fertility treatment.

Assisted Reproductive Technology Market Drivers

Rise in the Adoption of Ovulation Induction and Artificial Insemination in Developed Nations.

Various technologies such as ovulation induction, artificial insemination, and cryopreservation are increasingly being used among developed nations owing to the growing awareness about the presence of various medical procedures to address infertility. The key players are also focusing on developing advanced methods to meet the demand for addressing infertility, which is further propelling the growth of the Assisted Reproductive Technology Market.

Increase in the Median Age of First-Time Motherhood.

There is an increase in the median age of first-time motherhood owing to the factors such as improved contraceptive techniques and the increasing number of women prioritizing careers over starting a family. Moreover, the rate of first-time pregnancies in women under the age of 20 in developed nations has decreased rapidly, which is one of the major factors driving the growth of the Assisted Reproductive Technology Market.

Assisted Reproductive Technology Market Challenges 

High Cost of Assisted Reproductive Technology.

The government of several nations and other organizations are increasing their initiatives to enhance awareness among people about the presence of various technologies to address infertility. However, the high cost of assisted reproductive technologies to treat infertility is one of the major factors that is estimated to reduce the growth of the Assisted Reproductive Technology Market.

Assisted Reproductive Technology Market Competitive Landscape:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Assisted Reproductive Technology Market. Key companies of this market are Cosmos Biomedical, FUJIFILM Irvine Scientific, Microm UK Ltd, Origio, Parallabs, Cryolab Ltd, Ferring Pharmaceuticals, Ovascience, Merck Group, and Vitrolife AB among others.

Acquisitions/Product Launches:

  • In September 2019, FUJIFILM Irvine Scientific Inc, a world leader in the development and manufacture of Assisted Reproductive Technologies (ART) has launched Kit-NX to vitrify embryos in a consistent and stable environment to achieve high pregnancy rates.
  • In February 2019, Merck has launched fertility technologies, such as Geri, Gavi, and Gems to be made to IVF clinics and hospitals. These technologies help in reducing external stresses on the embryos of patients undergoing fertility treatment.
  • In January 2019, Ferring Pharmaceuticals has acquired the generic version of Ganirelix Acetate Injection from Sun Pharmaceutical Industries Ltd to expertise in the field of assisted reproductive technologies (ART) and to expand their service offerings to include various procedures.

Relevant Reports

Report Code: HCR 0971

Report Code: HCR 0079

For more Lifesciences and Healthcare Market reports, please click here
1. Assisted Reproductive Technology Market - Overview
    1.1 Definitions and Scope
2. Assisted Reproductive Technology Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Type
    2.3 Key trends by End User
    2.4 Key trends by Geography
3. Assisted Reproductive Technology Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Assisted Reproductive Technology Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Assisted Reproductive Technology Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Assisted Reproductive Technology Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Assisted Reproductive Technology Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Assisted Reproductive Technology Market – By Type(Market Size –$Million/$Billion)
    8.1 Ovulation Induction
    8.2 Artificial Insemination
    8.3 Surrogacy
    8.4 Others
9. Assisted Reproductive Technology Market – By Procedure(Market Size –$Million/$Billion)
    9.1 Fresh Nondonor
    9.2 Frozen Nondonor
    9.3 Fresh Donor
    9.4 Frozen Donor
10. Assisted Reproductive Technology Market – By End User(Market Size –$Million/$Billion)
    10.1 Hospitals
    10.2 Fertility Clinics
    10.3 Clinical Research Institutes
    10.4 Others
11. Assisted Reproductive Technology Market - By Geography(Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Mexico
        11.1.3 Canada
    11.2 Europe
        11.2.1 U.K.
        11.2.2 France
        11.2.3 Germany
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia Pacific
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Assisted Reproductive Technology Market - Entropy
13. Assisted Reproductive Technology Market – Industry/Segment Competition Landscape Premium
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Best Practices for Companies
14. Assisted Reproductive Technology Market – Key Company List by Country Premium Premium
15. Assisted Reproductive Technology Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global Competitive Landscape Market 2019-2024 ($M)
2.Global Competitive Landscape Market 2019-2024 (Volume/Units)
3.North America Competitive Landscape Market 2019-2024 ($M)
4.South America Competitive Landscape Market 2019-2024 ($M)
5.Europe Competitive Landscape Market 2019-2024 ($M)
6.APAC Competitive Landscape Market 2019-2024 ($M)
7.MENA Competitive Landscape Market 2019-2024 ($M)

LIST OF FIGURES

1.US Assisted Reproductive Technology Market Revenue, 2019-2024 ($M)
2.Canada Assisted Reproductive Technology Market Revenue, 2019-2024 ($M)
3.Mexico Assisted Reproductive Technology Market Revenue, 2019-2024 ($M)
4.Brazil Assisted Reproductive Technology Market Revenue, 2019-2024 ($M)
5.Argentina Assisted Reproductive Technology Market Revenue, 2019-2024 ($M)
6.Peru Assisted Reproductive Technology Market Revenue, 2019-2024 ($M)
7.Colombia Assisted Reproductive Technology Market Revenue, 2019-2024 ($M)
8.Chile Assisted Reproductive Technology Market Revenue, 2019-2024 ($M)
9.Rest of South America Assisted Reproductive Technology Market Revenue, 2019-2024 ($M)
10.UK Assisted Reproductive Technology Market Revenue, 2019-2024 ($M)
11.Germany Assisted Reproductive Technology Market Revenue, 2019-2024 ($M)
12.France Assisted Reproductive Technology Market Revenue, 2019-2024 ($M)
13.Italy Assisted Reproductive Technology Market Revenue, 2019-2024 ($M)
14.Spain Assisted Reproductive Technology Market Revenue, 2019-2024 ($M)
15.Rest of Europe Assisted Reproductive Technology Market Revenue, 2019-2024 ($M)
16.China Assisted Reproductive Technology Market Revenue, 2019-2024 ($M)
17.India Assisted Reproductive Technology Market Revenue, 2019-2024 ($M)
18.Japan Assisted Reproductive Technology Market Revenue, 2019-2024 ($M)
19.South Korea Assisted Reproductive Technology Market Revenue, 2019-2024 ($M)
20.South Africa Assisted Reproductive Technology Market Revenue, 2019-2024 ($M)
21.North America Assisted Reproductive Technology By Application
22.South America Assisted Reproductive Technology By Application
23.Europe Assisted Reproductive Technology By Application
24.APAC Assisted Reproductive Technology By Application
25.MENA Assisted Reproductive Technology By Application